Wayne T. Smith - Mar 1, 2025 Form 4 Insider Report for COMMUNITY HEALTH SYSTEMS INC (CYH)

Role
Director
Signature
Christopher G. Cobb, Attorney in Fact for Wayne T. Smith
Stock symbol
CYH
Transactions as of
Mar 1, 2025
Transactions value $
$0
Form type
4
Date filed
3/3/2025, 06:02 PM
Previous filing
Feb 21, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYH Common Stock Options Exercise $0 +30.2K +0.58% $0.00 5.24M Mar 1, 2025 Direct F1
holding CYH Common Stock 1.61M Mar 1, 2025 by The Modified 2009 WTS Irrev Trust Dated 12/16/22
holding CYH Common Stock 482K Mar 1, 2025 WAC LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYH Performance Based Restricted Options Exercise $0 -30.2K -16.8% $0.00 150K Mar 1, 2025 Common Stock 30.2K $0.00 Direct F1
transaction CYH Performance Based Restricted Disposed to Issuer $0 -150K -100% $0.00 0 Mar 1, 2025 Common Stock 150K $0.00 Direct F1
transaction CYH Restricted Stock Units Award $0 +59.8K +26.3% $0.00 287K Mar 1, 2025 Common Stock 59.8K $0.00 Direct F2
holding CYH Stock Options (Right to Buy) 78.8K Mar 1, 2025 Common Stock 78.8K $4.99 Direct
holding CYH Stock Options (Right to Buy) 113K Mar 1, 2025 Common Stock 113K $4.93 Direct
holding CYH Stock Options (Right to Buy) 90K Mar 1, 2025 Common Stock 90K $8.81 Direct
holding CYH Stock Options (Right to Buy) 90K Mar 1, 2025 Common Stock 90K $10.18 Direct
holding CYH Stock Units (SU) 35.6K Mar 1, 2025 Common Stock 35.6K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The vesting of these 180,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2022-2024 Performance Period, the award vested on March 1, 2025 at 16.8% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2022 (30,240), and the remaining 83.2% of the target number has been forfeited (149,760).
F2 These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral elections pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person.
F3 The Stock Units were accrued under the Company's Directors' Fees Deferral Plan in lieu of a portion of the Reporting Person's Director Fees and are settled 100% in the Company's common stock on the last business day of the calendar quarter following cessation as a director or upon a date specified by the Reporting Person.